Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Nymox Pharm Corp (NYMX)

Nymox Pharm Corp (NYMX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.2000 -0.0490 (-19.68%) 07/06/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.2000 unch (unch) -
Quote Overview for Thu, Jul 6th, 2023
Day Low
0.1827
Day High
0.2200
Open 0.2200
Previous Close 0.2490 0.2490
Volume 932,700 932,700
Avg Vol 309,280 309,280
Stochastic %K 27.46% 27.46%
Weighted Alpha -62.47 -62.47
5-Day Change -0.0816 (-28.98%) -0.0816 (-28.98%)
52-Week Range 0.1688 - 0.7427 0.1688 - 0.7427
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,103
  • Shares Outstanding, K 90,515
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,580 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.64
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings $-0.02 on 05/12/23
  • Next Earnings Date 08/21/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1688 +18.48%
on 06/30/23
Period Open: 0.4077
0.4170 -52.04%
on 06/16/23
-0.2077 (-50.94%)
since 06/06/23
3-Month
0.1688 +18.48%
on 06/30/23
Period Open: 0.3559
0.4950 -59.60%
on 05/08/23
-0.1559 (-43.80%)
since 04/06/23
52-Week
0.1688 +18.48%
on 06/30/23
Period Open: 0.4000
0.7427 -73.07%
on 12/08/22
-0.2000 (-50.00%)
since 07/06/22

Most Recent Stories

More News
Nymox: Q3 Earnings Snapshot

Nymox: Q3 Earnings Snapshot

NYMX : 0.2000 (-19.68%)
Nymox: Q2 Earnings Snapshot

Nymox: Q2 Earnings Snapshot

NYMX : 0.2000 (-19.68%)
NYMOX Updates Shareholders

IRVINE, Calif., July 15, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced an update to its shareholders regarding...

NYMX : 0.2000 (-19.68%)
NYMOX Receives Deficiency Letter from NASDAQ

IRVINE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) reports that on July 7, 2022 the Company received a...

NYMX : 0.2000 (-19.68%)
NYMOX Receives RTF letter from FDA

IRVINE, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) reports today that it has received a Refusal to File...

NYMX : 0.2000 (-19.68%)
Nymox Announces Closing of $6.4 Million Financing

IRVINE, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it has...

NYMX : 0.2000 (-19.68%)
Nymox Announces $5 Million Registered Direct Offering

IRVINE, Calif., March 18, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced it has entered into definitive...

NYMX : 0.2000 (-19.68%)
NYMOX Announces Submission of New Drug Application (NDA) to the FDA for Fexapotide Triflutate

IRVINE, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce today that it...

NYMX : 0.2000 (-19.68%)
Nymox Shareholder Update

HASBROUCK HEIGHTS, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it...

NYMX : 0.2000 (-19.68%)
NYMOX Presenting at Torrey Hills Capital Emerging Growth Conference

NYMOX Provides Current Update...

NYMX : 0.2000 (-19.68%)
Nymox: Q3 Earnings Snapshot

NASSAU, Bahamas (AP) _ Nymox Pharmaceutical Corp. (NYMX) on Friday reported a loss of $3.3 million in its third quarter.

NYMX : 0.2000 (-19.68%)
NYMOX Provides Current Update

HASBROUCK HEIGHTS, N.J., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to report today a...

NYMX : 0.2000 (-19.68%)
NYMOX Provides Shareholder Update

HASBROUCK HEIGHTS, N.J., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to provide an update on the Company's progress with its BPH...

NYMX : 0.2000 (-19.68%)
Nymox Announces Date for Fexapotide Filing

HASBROUCK HEIGHTS, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it will be filing for marketing approval of Fexapotide...

NYMX : 0.2000 (-19.68%)
Nymox Announces $8,000,000 Private Placement

HASBROUCK HEIGHTS, N.J., April 28, 2021 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) today announced it has entered into a definitive agreement with institutional...

NYMX : 0.2000 (-19.68%)

Business Summary

Nymox Pharmaceutical Corporation is engaged in the research and development of drugs and diagnostic products. The company offers products such as AlzheimAlert, NicAlert and TobacAlert tests. It markets its products primarily in the United States, Canada, and Europe. Nymox Pharmaceutical Corporation is...

See More

Key Turning Points

3rd Resistance Point 0.2564
2nd Resistance Point 0.2382
1st Resistance Point 0.2191
Last Price 0.2000
1st Support Level 0.1818
2nd Support Level 0.1636
3rd Support Level 0.1445

See More

52-Week High 0.7427
Fibonacci 61.8% 0.5235
Fibonacci 50% 0.4557
Fibonacci 38.2% 0.3880
Last Price 0.2000
52-Week Low 0.1688

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies